Biogen Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2007 | $1.02B | $734.6M | $284.1M | $123.1M |
| FY2008 | $1.56B | $1.29B | $276.0M | $146.2M |
| FY2009 | $1.07B | $909.3M | $165.6M | $160.9M |
| FY2010 | $1.62B | $1.45B | $173.1M | $167.8M |
| FY2011 | $1.73B | $1.52B | $208.0M | $113.0M |
| FY2012 | $1.88B | $1.63B | $254.5M | $118.6M |
| FY2013 | $2.35B | $2.10B | $246.3M | $136.3M |
| FY2014 | $2.94B | $2.65B | $287.8M | $155.3M |
| FY2015 | $3.92B | $3.28B | $643.0M | $161.4M |
| FY2016 | $4.59B | $3.97B | $616.1M | $154.8M |
| FY2017 | $4.55B | $3.68B | $867.4M | $128.0M |
| FY2018 | $6.19B | $5.42B | $770.6M | $157.5M |
| FY2019 | $7.08B | $6.56B | $514.5M | $182.3M |
| FY2020 | $4.23B | $3.81B | $424.8M | $198.3M |
| FY2021 | $3.64B | $3.38B | $258.1M | $238.6M |
| FY2022 | $1.38B | $1.14B | $240.3M | $254.1M |
| FY2023 | $1.55B | $1.27B | $277.0M | $264.2M |
| FY2024 | $2.88B | $2.72B | $153.7M | $291.2M |
| FY2025 | $2.20B | $2.05B | $153.8M | $290.8M |